CD19 and hypertensive disorder: Specifically, hypertension, higher calcineurin, use of mTOR inhibitors, higher dose of mycophenolate, as well as lower absolute B-cell counts contributed to low response (46), while higher CD19+ B cell counts were associated with sero-response (46).